Liver and GB remainder of part I and part II Flashcards
pathogenesis of alcoholic steatosis
- increased lipogenesis
- increase release of FA from fat cells
increased storage of FA in the liver - increased lipolysis
- decreased/lack of lipophagy
- decreased adipokines
- decreased release of VLDL from the liver
pathogenesis of alcoholic steatohepatitis
- cytokines by kupffer cells
- ROS
- toxic alcohol metabolites
- fibrosis by stellate cells
etiology of cirrhosis
- HBV
- HCV
- Alcoholic liver disease
- Hemochromatosis
- Nonalcoholic fatty liver disease
compensated cirrhosis
w or w/o gastroesophageal varices
No sign of hepatic damage
decomp cirrhosis
Jaundice
Hepatic encephalopathy
Ascites
Variceal hemorrhage
portal hypertension
structural changes: fibrosis
dynamic changes: increased vasoconstrictors
decreased vasodilators
ascites
- Main clinical consequences of portal hypertension
- portal hypertension -> Splanchnic Arterial Vasodilation -> Decrease in Effective Arterial Volume -> Decrease in Renal Blood Flow -> renin-angiotensin activation
Clinical consequences of iron overload
- increased non-transferrin-bound iron (NTBI)
- excess oxygen radicals
Hereditary Hemochromatosis
- HFE gene mutation -> reduced hepcidin
- Lipid peroxidation
- Interaction of ROS and iron with DNA
- Stimulation of collagen formation
- Clinical consequence: Fibrosis and cirrhosis
HAV
- no chronic infection
- oral-fecal route
- vaccination
- lifelong immunity
- Hepatocellular damage and destruction by HAV-specific CD8+ T lymphocytes and NK cells
Interferon-gamma
symptomes: Sudden onset of nausea, vomiting, anorexia, fever, malaise and abdominal pain
Within a few days to a week, dark urine, pale stools followed by jaundice and pruritus
HBV
- cccDNA -> chronic infection
- blood, birth, bonking
- Immune-mediated liver injury
Cytotoxic T cell-mediated lysis
Direct cytotoxic liver injury
Role of viral variants
phases of HBV infection
Immune-tolerance phase
- HBeAg-positive
- high levels of HBV replication with normal ALT levels
- limited liver inflammation
Immune-clearance/reactive phase
- ALT levels are typically elevated or fluctuating,
- higher risk of liver fibrosis
Immune-control phase
- very low or undetectable HBV DNA levels
- normal ALT and minimal fibrosis progression
- anti-HBe positive
Immune-escape phase
- in some people
- rising HBV DNA levels despite HBeAg negativity
- caused by virions that do not express HBeAg because of genetic mutations
- anti-HBe positive
HCV
- mutation - > viral persistence -> chronic HCV hepatitis
pathogenesis: - Chronic hepatitis C
- Liver cirrhosis
- Hepatocellular carcinoma
- uses many cancer hallmarks
NAFLD types
- NAFL: nonalcoholic fatty liver: hepatic steatosis is present without evidence of inflammation
- NASH: nonalcoholic steatohepatitis may progress to cirrhosis
pathogenesis of NASH
- Kupffer cells:
pro-inflammatory mediators and pro-fibrotic factors - Stellate cells:
fibrogenesis - Hepatocytes
FC accumulation in the mitochondria -> ROS and lipid peroxidation